These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 30866858

  • 1. 18F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications.
    Ye S, Liu S, Xiang L, Wu X, Yang H.
    BMC Cancer; 2019 Mar 13; 19(1):226. PubMed ID: 30866858
    [Abstract] [Full Text] [Related]

  • 2. The role of 18F-FDG PET/CT-based quantitative metabolic parameters in patients with ovarian clear cell carcinoma.
    Ye S, Liu S, Zhou S, Xiang L, Wu X, Yang H.
    Cancer Biomark; 2020 Mar 13; 27(2):189-194. PubMed ID: 31796665
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of 18 F-FDG PET/CT parameters in patients who undergo salvage treatments for recurrent squamous cell carcinoma of the larynx and hypopharynx.
    Lee JR, Almuhaimid TM, Roh JL, Oh JS, Kim SJ, Kim JS, Choi SH, Nam SY, Kim SY.
    J Surg Oncol; 2018 Sep 13; 118(4):644-650. PubMed ID: 30132891
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of (18)F-FDG PET/CT volumetric parameters in recurrent epithelial ovarian cancer.
    Mayoral M, Fernandez-Martinez A, Vidal L, Fuster D, Aya F, Pavia J, Pons F, Lomeña F, Paredes P.
    Rev Esp Med Nucl Imagen Mol; 2016 Sep 13; 35(2):88-95. PubMed ID: 26541072
    [Abstract] [Full Text] [Related]

  • 5. Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer.
    Kim CY, Jeong SY, Chong GO, Son SH, Jung JH, Kim DH, Lee SW, Ahn BC, Lee J.
    Gynecol Oncol; 2015 Mar 13; 136(3):498-504. PubMed ID: 25557270
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW, Oh JS, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY.
    Eur J Nucl Med Mol Imaging; 2015 Aug 13; 42(9):1353-61. PubMed ID: 26067088
    [Abstract] [Full Text] [Related]

  • 7. Prognostic values of mid-radiotherapy 18F-FDG PET/CT in patients with esophageal cancer.
    Kim N, Cho H, Yun M, Park KR, Lee CG.
    Radiat Oncol; 2019 Feb 04; 14(1):27. PubMed ID: 30717809
    [Abstract] [Full Text] [Related]

  • 8. F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer.
    Gallicchio R, Nardelli A, Venetucci A, Capacchione D, Pelagalli A, Sirignano C, Mainenti P, Pedicini P, Guglielmi G, Storto G.
    Eur J Radiol; 2017 Aug 04; 93():107-113. PubMed ID: 28668403
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer.
    Chung HH, Kwon HW, Kang KW, Park NH, Song YS, Chung JK, Kang SB, Kim JW.
    Ann Surg Oncol; 2012 Jun 04; 19(6):1966-72. PubMed ID: 22124757
    [Abstract] [Full Text] [Related]

  • 11. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH, Jung DW, Pak KJ, Kim IJ, Kim HJ, Cho JK, Shin SC, Wang SG, Lee BJ.
    Head Neck; 2018 Jan 04; 40(1):94-102. PubMed ID: 29130586
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan 04; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 13. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
    Satoh Y, Onishi H, Nambu A, Araki T.
    Radiology; 2014 Jan 04; 270(1):275-81. PubMed ID: 24029640
    [Abstract] [Full Text] [Related]

  • 14. Maximum standardized uptake value of fluorodeoxyglucose positron emission tomography/computed tomography is a prognostic factor in ovarian clear cell adenocarcinoma.
    Konishi H, Takehara K, Kojima A, Okame S, Yamamoto Y, Shiroyama Y, Yokoyama T, Nogawa T, Sugawara Y.
    Int J Gynecol Cancer; 2014 Sep 04; 24(7):1190-4. PubMed ID: 24987918
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
    Pak K, Kim BS, Kim K, Kim IJ, Jun S, Jeong YJ, Shim HK, Kim SD, Cho KS.
    Am J Otolaryngol; 2018 Sep 04; 39(1):1-5. PubMed ID: 29056243
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.
    Alongi P, Caobelli F, Gentile R, Stefano A, Russo G, Albano D, Baldari S, Gilardi MC, Midiri M.
    Eur J Nucl Med Mol Imaging; 2017 Feb 04; 44(2):224-233. PubMed ID: 27565154
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.
    Hwang SH, Cho A, Yun M, Choi YD, Rha SY, Kang WJ.
    Clin Nucl Med; 2017 May 04; 42(5):e235-e241. PubMed ID: 28288043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.